LIPOXIN B4
- CAS No.
- 98049-69-5
- Chemical Name:
- LIPOXIN B4
- Synonyms
- LXB4;LIPOXIN B4;5(S),14(R)-Lipoxin B4;UXVRTOKOJOMENI-WLPVFMORSA-N;5(S), 14(R), 15(S)-TRIHYDROXYEICOSA-6E,8Z,10E,12E-TETRAENOIC ACID;(5S,14R,15S)-5,14,15-Trihydroxy-(6E,8Z,10E,12E)-eicosatetraenoic acid;(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxy-6,8,10,12-icosatetraenoic acid;(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-trihydroxyicosa-6,8,10,12-tetraenoic acid;6,8,10,12-Eicosatetraenoic acid, 5,14,15-trihydroxy-, (5S,6E,8Z,10E,12E,14R,15S)-
- CBNumber:
- CB0701080
- Molecular Formula:
- C20H32O5
- Molecular Weight:
- 352.47
- MDL Number:
- MFCD00870250
- MOL File:
- 98049-69-5.mol
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H315-H319-H335 | |||||||||
| Precautionary statements | P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362 | |||||||||
| Hazard Codes | F,Xi | |||||||||
| Risk Statements | 11-36/37/38 | |||||||||
| Safety Statements | 16-26-36 | |||||||||
| NFPA 704 |
|
LIPOXIN B4 price More Price(7)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 90420 | Lipoxin B4 ≥95% | 98049-69-5 | 25μg | $274 | 2024-03-01 | Buy |
| Cayman Chemical | 90420 | Lipoxin B4 ≥95% | 98049-69-5 | 50μg | $519 | 2024-03-01 | Buy |
| Cayman Chemical | 90420 | Lipoxin B4 ≥95% | 98049-69-5 | 100μg | $980 | 2024-03-01 | Buy |
| Usbiological | 396443 | LXB4 | 98049-69-5 | 48Tests | $588 | 2021-12-16 | Buy |
| TRC | L468770 | 5(S),14(R)-LipoxinB4 | 98049-69-5 | 50μg | $600 | 2021-12-16 | Buy |
LIPOXIN B4 Chemical Properties,Uses,Production
Uses
Lipoxins are a series of anti-inflammatory lipid mediators whose brief appearance generally signals the resolution of inflammation. Lipoxin A4 (LXA4) is a potent inhibitor of leukotriene (LT)-triggered polymorphonuclear neutrophil (PMN)-endothelial cell interaction and also blocks PMN migration stimulated by LTB4. LXB4 is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15-HpETE by human leukocytes. At a concentration of 10-7 M, LXB4 inhibits PMN migration stimulated by LTB4 and inhibits LTB4-induced adhesion of PMNs with an IC50 value of ~3 X 10-10 M.
Uses
5(S),14(R)-Lipoxin B4 is a positional isomer of LXA4.
Definition
ChEBI: Lipoxin B4 is a C20 hydroxy fatty acid having (5S)-, (14R)- and (15S)-hydroxy groups as well as (6E)- (8Z)-, (10E)- and (12E)-double bonds. It has a role as a human metabolite. It is a lipoxin, a long-chain fatty acid and a hydroxy polyunsaturated fatty acid. It is a conjugate acid of a lipoxin B4(1-).
LIPOXIN B4 Preparation Products And Raw materials
Raw materials
Preparation Products
LIPOXIN B4 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 821-50328103-801 18930552037 | 3bsc@sina.com | China | 15848 | 69 |
| ChemeGen(Shanghai) Biotechnology Co.,Ltd. | 18818260767 | sales@chemegen.com | China | 11289 | 58 |
| Shanghai Universal Biotech Co.,Ltd | 18768175414 | gaojun@univ-bio.com | China | 24998 | 58 |
| TargetMol Chemicals Inc. | 4008200310 | marketing@tsbiochem.com | China | 24131 | 58 |
| Shanghai Yiyan Biotechnology Co. , Ltd. | 021-69985186 13611928337 | 3427709316@qq.com | China | 7984 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 8740 | 58 |
98049-69-5(LIPOXIN B4)Related Search:
1of4